Cargando…
Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI
The outcome for T-cell acute lymphoblastic leukemia (T-ALL) in relapse after hematopoietic stem cell transplantation (HSCT) is quite poor, while, both donor lymphocytes infusion (DLI) and adoptively infusion of γδ T cells in leukemia patients after HSCT have demonstrated good results in prolonging s...
Autores principales: | Xu, Ling, Weng, Jianyu, Huang, Xin, Zeng, Chengwu, Chen, Shaohua, Geng, Suxia, Yang, Lijian, Wu, Suijing, Huang, Suming, Du, Xin, Li, Yangqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189998/ https://www.ncbi.nlm.nih.gov/pubmed/27356746 http://dx.doi.org/10.18632/oncotarget.10260 |
Ejemplares similares
-
The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation
por: Chen, Shaohua, et al.
Publicado: (2013) -
Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2010) -
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia
por: Huang, Xin, et al.
Publicado: (2015) -
Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
por: Xuan, Li, et al.
Publicado: (2016) -
Therapeutic Strategies for DLI: How Should DLI Be Treated?
por: Homma, Sakae
Publicado: (2017)